4.7 Article

A critical cysteine residue in monoacylglycerol lipase is targeted by a new class of isothiazolinone-based enzyme inhibitors

期刊

BRITISH JOURNAL OF PHARMACOLOGY
卷 157, 期 6, 页码 974-983

出版社

WILEY
DOI: 10.1111/j.1476-5381.2009.00276.x

关键词

monoacylglycerol lipase; 2-arachidonoylglycerol; endocannabinoids

资金

  1. NIDA NIH HHS [R01 DA012447, R01 DA-012447] Funding Source: Medline

向作者/读者索取更多资源

Background and purpose: Monoacylglycerol lipase (MGL) is a presynaptic serine hydrolase that inactivates the endocannabinoid neurotransmitter, 2-arachidonoyl-sn-glycerol. Recent studies suggest that cysteine residues proximal to the enzyme active site are important for MGL function. In the present study, we characterize the role of cysteines in MGL function and identify a series of cysteine-reactive agents that inhibit MGL activity with nanomolar potencies by interacting with cysteine residue 208. Experimental approach: A series of cysteine traps were screened for the ability to inhibit MGL in vitro. Rapid dilution assays were performed to determine reversibility of inhibition. Molecular modelling and site-directed mutagenesis were utilized to identify cysteine residues targeted by the inhibitors. Key results: The screening revealed that 2-octyl-4-isothiazolin-3-one (octhilinone) inhibited purified rat recombinant MGL (IC50 = 88 +/- 12 nM) through a partially reversible mechanism. Initial structure -activity relationship studies showed that substitution of the n-octyl group of octhilinone with a more lipophilic oleoyl group increased inhibitor potency (IC50 = 43 +/- 8 nM), while substitution with a methyl group produced the opposite effect (IC50 = 239 +/- 68 nM). The inhibitory potency of octhilinone was selectively decreased by mutating cysteine 208 in MGL to glycine (IC50; wild-type, 151 +/- 17 nM; C208G, 722 +/- 74 nM), but not by mutation of other cysteine residues (C32, C55, C201, C208 and C242). Conclusions and implications: The results indicated that cysteine 208 plays an important role in MGL function and identified a novel class of isothiazolinone-based MGL inhibitors with nanomolar potency in vitro. British Journal of Pharmacology (2009) 157, 974-983; doi:10.1111/j.1476-5381.2009.00276.x; published online 26 May 2009

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据